Rebalance Health
PrivateLast Round
Series C
Aug 14, 2023
Est. Valuation
$31.37M
Total Funding Raised
$21.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rebalance Health is a health and wellness company that offers products made with nutrients and adaptogens intended to optimize health and fitness by targeting cortisol and hormone levels.
Sector
Healthcare & Life Sciences
Verticals
D2C Brands, Subscription Commerce, Mental Health
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebalance Health Comparables
Compare Rebalance Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmavite LLC | 79% | |
| dsm-firmenich | 78% | |
| O Positiv Health | 78% |
Rebalance Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 14, 2023 | ||||
| Series B | May 6, 2022 | ||||
| Series A | Nov 9, 2021 |
Key People
Founding team and executive leadership
Rebalance Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALMA Life Sciences | Series B, Series A |
| The Ropart Asset Management Funds | Series B, Series A |
| Sage Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 56% MoM to 7.3K.
- Mar 7, 2025
Launched the Rebalance Anxiety System to promote calm and focus.
Rebalance Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rebalance Health's valuation, stock price, and market status.
Is Rebalance Health a public or private company?
Rebalance Health is a private company.
What is the current stock price of Rebalance Health?
Rebalance Health is a private company with no public stock price. No recent secondary market data is available.
How much is Rebalance Health worth (valuation)?
Rebalance Health's valuation is estimated at $31.4M based on funding round data.
Can I buy Rebalance Health stock?
Rebalance Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rebalance Health's last funding round?
Rebalance Health's most recent funding round was Series C on August 28, 2023.
Who are the main investors in Rebalance Health?
Key investors in Rebalance Health include ALMA Life Sciences, The Ropart Asset Management Funds, Sage Venture Partners.
Will Rebalance Health IPO soon?
No public IPO plans have been announced for Rebalance Health.
How can I track Rebalance Health secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rebalance Health's secondary market activity and sign up for updates.